These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34266477)

  • 21. Practice-based teaching for health policy action and advocacy.
    Hearne SA
    Public Health Rep; 2008; 123 Suppl 2(Suppl 2):65-70. PubMed ID: 18770919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of Australia's front-of-pack interpretative nutrition labelling Health Star Rating system: lessons for public health advocates.
    Moore M; Jones A; Pollard CM; Yeatman H
    Aust N Z J Public Health; 2019 Aug; 43(4):352-354. PubMed ID: 31141259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Theoretically Derived Approach to Impact: Implementing Policy Influence Strategies.
    De Raeve P; Bolzonella F; Davidson PM
    Policy Polit Nurs Pract; 2022 Aug; 23(3):150-161. PubMed ID: 35656783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding Barriers and Enablers to State Action on Salt: Analysis of Stakeholder Perceptions of the VicHealth Salt Reduction Partnership.
    McKenzie B; Trieu K; Grimes CA; Reimers J; Webster J
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30654526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using the Advocacy Coalition Framework to understand EU pharmaceutical policy.
    Brooks E
    Eur J Public Health; 2018 Nov; 28(suppl_3):11-14. PubMed ID: 30383259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Policy implementation and outcome evaluation: establishing a framework and expanding capacity for advocacy organizations to assess the impact of their work in public policy.
    Whitsel LP; Honeycutt S; Radcliffe R; Johnson J; Chase PJ; Noyes P
    Health Res Policy Syst; 2024 Feb; 22(1):27. PubMed ID: 38378597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Australia's Health Star Rating policy process: Lessons for global policy-making in front-of-pack nutrition labelling.
    Kumar M; Gleeson D; Barraclough S
    Nutr Diet; 2018 Apr; 75(2):193-199. PubMed ID: 29130589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advocacy evaluation: challenges and emerging trends.
    Devlin-Foltz D; Fagen MC; Reed E; Medina R; Neiger BL
    Health Promot Pract; 2012 Sep; 13(5):581-6. PubMed ID: 22773623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drop the Salt! Assessing the impact of a public health advocacy strategy on Australian government policy on salt.
    Webster J; Dunford E; Kennington S; Neal B; Chapman S
    Public Health Nutr; 2014 Jan; 17(1):212-8. PubMed ID: 23171657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generating political priority for alcohol policy reform: A framework to guide advocacy and research.
    Gage R; Connor J; Jackson N; McKerchar C; Signal L
    Drug Alcohol Rev; 2024 Feb; 43(2):381-392. PubMed ID: 38017702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Assessment of Family Planning Decision Makers' and Advocates' Needs and Strategies in Three East African Countries.
    Smith E; Musila R; Murunga V; Godbole R
    Int Perspect Sex Reprod Health; 2015 Sep; 41(3):136-44. PubMed ID: 26600567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How are evidence generation partnerships between researchers and policy-makers enacted in practice? A qualitative interview study.
    Williamson A; Tait H; El Jardali F; Wolfenden L; Thackway S; Stewart J; O'Leary L; Dixon J
    Health Res Policy Syst; 2019 Apr; 17(1):41. PubMed ID: 30987644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advocacy coalition impacts on healthy public policy-oriented learning in Alberta, Canada (2009-2016): A difference-in-differences analysis.
    Nykiforuk CIJ; McGetrick JA; Raine KD; Wild TC
    Soc Sci Med; 2019 Jan; 220():31-40. PubMed ID: 30391639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pill testing policy: A comparative analysis using the Advocacy Coalition Framework.
    Sommerville K; Ritter A; Stephenson N
    Drug Alcohol Rev; 2022 Jan; 41(1):275-284. PubMed ID: 34252242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Setting strategy for system change: using concept mapping to prioritise national action for chronic disease prevention.
    Wutzke S; Roberts N; Willis C; Best A; Wilson A; Trochim W
    Health Res Policy Syst; 2017 Aug; 15(1):69. PubMed ID: 28784177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Creating 'healthy built environment' legislation in Australia; a policy analysis.
    Harris P; Kent J; Sainsbury P; Marie-Thow A; Baum F; Friel S; McCue P
    Health Promot Int; 2018 Dec; 33(6):1090-1100. PubMed ID: 28973409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scaling up population health interventions from decision to sustainability - a window of opportunity? A qualitative view from policy-makers.
    Lee K; van Nassau F; Grunseit A; Conte K; Milat A; Wolfenden L; Bauman A
    Health Res Policy Syst; 2020 Oct; 18(1):118. PubMed ID: 33036633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using the Advocacy Coalition Framework and Multiple Streams policy theories to examine the role of evidence, research and other types of knowledge in drug policy.
    Ritter A; Hughes CE; Lancaster K; Hoppe R
    Addiction; 2018 Aug; 113(8):1539-1547. PubMed ID: 29664153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Professional advocacy: linking Virginia's story to public policy-making theory, learning from the past and applying it to our future.
    Eaton MK
    Policy Polit Nurs Pract; 2012 May; 13(2):105-12. PubMed ID: 22807492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing evidence use in public health nutrition policymaking: theoretical insights from a New Zealand case study.
    Field P; Gauld R; Lawrence M
    Health Res Policy Syst; 2016 Nov; 14(1):84. PubMed ID: 27887613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.